New-generation GLP-1 drugs, such as retatrutide, are achieving higher rates of weight loss. How much weight is too much and ...
Patients with relapsed multiple myeloma treated with the immunotherapy teclistamab lived significantly longer and remained in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results